The largest database of trusted experimental protocols

Jupiter c18 column

Manufactured by Phenomenex
Sourced in United States, United Kingdom, Japan, Germany

The Jupiter C18 column is a reversed-phase high-performance liquid chromatography (HPLC) column designed for separating and analyzing a wide range of chemical compounds. It features a silica-based stationary phase with C18 alkyl functional groups, which provide a hydrophobic surface for the retention of non-polar and moderately polar analytes. The column is suitable for use in a variety of HPLC applications, including pharmaceutical, environmental, and food analysis.

Automatically generated - may contain errors

73 protocols using jupiter c18 column

1

Radiolabeled DOTA-PEG Peptide Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO), unless otherwise specified. Aqueous solutions were prepared using ultrapure water (resistivity, 18.2 MΩ·cm). Rink amide 4-methylbenzhydrylamine resin (loading, 0.77 mmol/g), and all Fmoc-protected amino acid were purchased from Chem-Impex International, Inc. (Wood Dale, IL). DOTA was purchased from CheMatec (Dijon, France). Fmoc-PEG4 carboxylic acid was purchased from ChemPep Inc. (Wellington, FL). 177LuCl3 was purchased from the University of Missouri Research Reactor Center (Columbia, MO). Analytical and semipreparative reversed-phase high-performance liquid chromatography (HPLC) were performed on a Waters 1525 Binary HPLC pump (Milford, MA) with a Waters 2489 UV–vis detector and a model 106 Bioscan radioactivity detector (Bioscan Inc., Washington, DC). Nonradioactive HPLC samples were analyzed on an analytical Jupiter C18 column and purified on a semipreparative Jupiter C18 column (Phenomenex, Torrance, CA). Radiochemistry reaction progress and purity were monitored on a Jupiter C18 column (Phenomenex, Torrance, CA). Radioactive samples were counted using either an automated Packard Cobra II gamma counter (Packard, Ramsey, MN) or a PerkinElmer 2470 WIZARD2 Automatic Gamma Counter (Waltham, MA). PET/CT data were acquired using an Inveon Preclinical Imaging Station (Siemens Medical Solutions).
+ Open protocol
+ Expand
2

Analytical and Preparative HPLC Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analytical and semi-preparative reversed-phase high-performance liquid chromatography (HPLC) were performed on a Waters 1525 Binary HPLC pump (Milford, MA) with a Waters 2489 UV/visible detector and a model 106 Bioscan radioactivity detector (Bioscan inc., Washington, DC). Non-radioactive HPLC samples were analyzed on an analytical Jupiter C18 column and purified on a semi-preparative Jupiter C18 column (Phenomenex, Torrance, CA). Radiochemistry reaction progress and purity were monitored on a Jupiter C18 column (Phenomenex, Torrance, CA) or TLC scanner (Bioscan System 200; Eckert & Ziegler, Hopkinton, MA). PET/CT data were acquired using a small animal Inveon Preclinical Imaging Station (Siemens Medical Solutions, Knoxville, TN).
+ Open protocol
+ Expand
3

Analytical RP-HPLC Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analytical RP-HPLC was performed on a Knauer (Herbert Knauer GmbH, Berlin, Germany) HPLC system using a Phenomenex Jupiter C18 column (250x4.6mm I.D.) with 5 µm silica (300 Å pore size) (Torrance, CA USA) as a stationary phase. Linear gradient elution (0 min 0% B; 5 min 0% B; 50 min 90% B) with eluent A (0.1% TFA in water) and eluent B (0.1% TFA in acetonitrile-water (80:20, V/V)) was used at a flow rate of 1 mL/min at ambient temperature. Peaks were detected at λ = 220 nm. The samples were dissolved in eluent B. In the other cases Exformma (Exformma Technology (ASIA) Co., Ltd, Hong Kong, China) HPLC system was used. The column was Agilent Zorbax SB-C18 4.6mmx150mm, 100Å. The applied linear gradient elution was 0 min 0% B, 2 min 0% B, 22 min 90% B with 1 mL/min flow rate. The detection was carried on at λ = 220 nm. The crude products were purified on a semi-preparative Phenomenex Jupiter C18 column (250x10mm I.D.) with 10 µm silica (300 Å pore size) (Torrance, CA, USA). Flow rate was 4 mL/min. Linear gradient elution was applied. The samples for purification were dissolved in eluent A containing few percent eluent B.
+ Open protocol
+ Expand
4

Venom Fractionation from Scorpion H. waigiensis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venom samples were collected from H. waigiensis using a square-wave stimulator (Arthur H. T. Thomas Co. Scientific Apparatus, Philadelphia, PA, USA) to electrostimulate the venom gland at 25V DC, 0.5 ms pulse duration, at a frequency of 1 pulse/sec. The samples were pooled into 20 µL of MilliQ water and stored at −20 °C. Pooled samples collected on two separate dates were further pooled prior to analysis. A further five scorpions (two male and three female) were milked and the samples were stored separately in 30 µL of MilliQ water for LC/MS analysis.
Crude pooled venom was fractionated by reversed-phase HPLC (RP-HPLC) using a Phenomenex Jupiter® C18 column (250 × 10 mm, 10 µm, 100 Å; Phenomenex, Torrence, CA, USA). Fractionation of the venom components was achieved using a linear gradient of two mobile phases: H2O/0.05% trifluoroacetic acid (TFA; Auspep, Tullamarine, VIC, Australia) (solvent A) and 90% acetonitrile (ACN; Sigma-Aldrich, St. Louis, MO, USA)/H2O/0.045% TFA (solvent B). Separation used a gradient of 0–60% solvent B in 120 min, 60–90% solvent B in 5 min, 90% solvent B for 10 min, and 90–0% solvent B in 5 min, at a flow rate of 3 mL/min. The venom component elution was monitored at 214 nm and 280 nm, and 0.5 min fractions were collected.
+ Open protocol
+ Expand
5

Quantification of sCT in Aerosol Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concentration of sCT in aerosolization tests was determined by HPLC system (Shimadzu LC-20AT liquid chromatograph, Shimadzu Co., Ltd., Kyoto, Japan) equipped with a reverse-phase Phenomenex Jupiter C18 column (5 μm, 4.6 × 250 mm, Phenomenex Inc., Torrance, CA) at 40 °C with UV detection at 220 nm. Acetonitrile (mobile phase A)–0.02 mol/L TMAH solution (pH 2.5, mobile phase B) was adopted as mobile phase at 1.000 L/min. A program of dual gradient elution was run as T (min)/%mobile phase A: 0–15 min, 72%; 15–17 min, 63%; 17–30 min, 72%. Injection volume was adjusted to 100 μL. A calibration curve was constructed by sCT standard solutions of 0.8–50 μg/mL (R2 =0.9997). Each sample was quantified in triplicate.
+ Open protocol
+ Expand
6

Structural Analysis of NFAP Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Structural alterations of NFAP and its mutants were examined by RP-HPLC, using an Agilent 1100 Series liquid chromatograph (Agilent technologies, Little Falls, DE, USA) and a Phenomenex Jupiter C18 column (250 × 4.6 mm; 10 μm particle size; 300 Å pore size; Phenomenex, Torrance, CA, USA). Linear gradient elution was carried out with 0.1% TFA in water (eluent A) and 80% acetonitrile and 0.1% TFA is water (eluent B) from 15% to 40% (B) over 25 min at a flow rate of 1.0 ml/min.
+ Open protocol
+ Expand
7

Purification and Analysis of Crude Products

Check if the same lab product or an alternative is used in the 5 most similar protocols
The crude products were purified on a KNAUER 2501 HPLC system (KNAUER, Berlin, Germany) using a semipreparative Phenomenex Jupiter C 18 column (250 mm x 10 mm) with 10 µm silica (300 Å pore size; Gen-Lab Ltd., Budapest, Hungary). Linear gradient elution (10-75% B; 35 min) with eluent A (0.1% TFA in water) and eluent B (0.1% TFA in acetonitrile/H 2 O (80:20, v/v)) was used at a flow rate of 4 mL/min. Peaks were detected at 220 nm. Analytical RP-HPLC was performed on an Exformma EX1600 HPLC system (Gen-Lab Ltd., Budapest, Hungary) using an Agilent Zorbax SB-C 18 column (150 mm x 4.6 mm) with 5 µm silica, 80Å pore size (Kromat Ltd, Budapest, Hungary) as a stationary phase.
Linear gradient elution (0-90% B; 20 min) with eluent A (0.1% TFA in water) and eluent B (0.1% TFA in acetonitrile/H 2 O (80:20, v/v)) was used at a flow rate of 1 mL/min. Peaks were detected at 220 nm.
+ Open protocol
+ Expand
8

Protein Identification by Mass Spectrometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spots excised from 2D-PAGE were fully discolored and digested with trypsin. All mass spectrometric measurements were performed using a LTQ linear ion trap mass spectrometer (Thermo Electron) coupled to a HPLC Surveyor (Thermo Electron) equipped with a Jupiter C18 column 250 mm × 1 mm (Phenomenex). Protein identification was performed using SEQUEST software and searched against a Human protein database. Peptide MS/MS assignments were filtered following very high stringent criteria: Xcorr ≥1.9 for the singly charged ions, Xcorr ≥2.2 for doubly charged ions, Xcorr ≥3.7 for triply charged ions, peptide probability ≤0.01, delta Cn ≥0.1 and Rsp ≤4.26.
+ Open protocol
+ Expand
9

Synthesis and Purification of OsCEP1 Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
OsCEP1a (DVRHypTNPGHSHypGIGH), OsCEP1b (DVRHypTNHypGHSHypGIGH), OsCEP1c (GVRHypTNPGHSHypGIGH), and OsCEP1d (GVRHypTNHypGHSHypGIGH) were synthesized on a CS 136X synthesizer (CS Bio, Menlo Park, CA, USA) using Fmoc solid phase peptide synthesis chemistry. Hydroxyproline (Hyp) was introduced with Fmoc-Hyp(Boc)-OH purchased from Watanabe Chemical Industries, Ltd. (Hiroshima, Japan). The obtained crude peptides were purified by reverse-phase HPLC on Jasco, Inc. (Tokyo, Japan) preparative instruments with a Jupiter C18 column (5 µm, 300 Å pore size, 21.2-mm internal diameter ×250 mm) (Phenomenex, Torrance, CA, USA), and lyophilized to yield pure peptides.
+ Open protocol
+ Expand
10

Purification of Naja Venom Cytotoxins

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 600 mg sample of dried N. naja venom was dissolved in 0.1 M ammonium acetate buffer, pH 6.2, and applied to a Sephadex G50s column (4.5 × 150 cm) equilibrated in the same buffer. The column was eluted at flow rate 32 mL/min. The fractions obtained were pooled as shown in Figure S1A. Fraction V was further separated on a HEMA BIO 1000 CM column (8 × 250 mm) (Tessek, Prague, Czech Republic) in an ammonium acetate gradient from 5 to 700 mM (pH 7.5) in 140 min at flow rate 1.0 mL/min (Figure S1B). Fractions 14–18 were freeze-dried and further purified by reversed-phase chromatography on a Jupiter C18 column (10 × 250 mm, Phenomenex, Torrance, CA, USA) in a gradient of acetonitrile 25–35% in 60 min in the presence of 0.1% trifluoroacetic acid, at a flow rate of 2.0 mL/min. After freeze-drying, the obtained proteins were used for further studies. Molecular masses of the isolated products were determined by mass spectrometry [35 (link)]. A similar procedure was used to isolate cytotoxins from N. haje venom.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!